MOUNTAIN VALLEY MD HLDGS Market Cap ($16.44 Million)
Market Cap & Net Worth: MOUNTAIN VALLEY MD HLDGS (20MP)
MOUNTAIN VALLEY MD HLDGS market cap. MOUNTAIN VALLEY MD HLDGS (F:20MP) has a market capitalization of $16.44 Million (€14.06 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #25561 globally and #2190 in its home market, demonstrating a -5.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MOUNTAIN VALLEY MD HLDGS's stock price €0.04 by its total outstanding shares 352354962 (352.35 Million).
MOUNTAIN VALLEY MD HLDGS Market Cap History (2015–2026)
MOUNTAIN VALLEY MD HLDGS market cap history from 2015 to 2026. Data shows change from $21.01 Million to $16.44 Million (-6.93% CAGR). Check MOUNTAIN VALLEY MD HLDGS stock quote for real-time trading data and today's change.
MOUNTAIN VALLEY MD HLDGS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MOUNTAIN VALLEY MD HLDGS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 20MP by Market Capitalization
Companies near MOUNTAIN VALLEY MD HLDGS in the global market cap rankings as of November 4, 2026.
Key companies related to MOUNTAIN VALLEY MD HLDGS by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of MOUNTAIN VALLEY MD HLDGS (2015–2026)
Market capitalization of MOUNTAIN VALLEY MD HLDGS from 2015 to today. Between 2015 and today, MOUNTAIN VALLEY MD HLDGS's market cap moved from $21.01 Million to $ 16.44 Million, with a yearly change of -6.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €16.44 Million | +806.82% |
| 2025 | €1.81 Million | -54.17% |
| 2024 | €3.95 Million | -40.00% |
| 2023 | €6.59 Million | +5.26% |
| 2022 | €6.26 Million | -72.86% |
| 2021 | €23.07 Million | -83.53% |
| 2020 | €140.06 Million | +1985.89% |
| 2019 | €6.71 Million | +103.75% |
| 2018 | €3.30 Million | -93.33% |
| 2017 | €49.43 Million | +300.00% |
| 2016 | €12.36 Million | -41.18% |
| 2015 | €21.01 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of MOUNTAIN VALLEY MD HLDGS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.44 Million USD |
| MoneyControl | $16.44 Million USD |
| MarketWatch | $16.44 Million USD |
| marketcap.company | $16.44 Million USD |
| Reuters | $16.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MOUNTAIN VALLEY MD HLDGS
Mountain Valley MD Holdings Inc., a biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol solubility enhances solubility for previously insol… Read more